₨ 114,000.00
MBBS
MABTHERA 10mg|ml Injection 50mlx1s
- Does this requires a prescription ? Yes
- Generic Name: Rituximab:10mg/ml
- Manufactured by : Roche
- Drug Strength : 10mg/ml
- Drug Form : Injection
- Pack Size : 50mlx1s
- Product SKU : dis_20467
Rituximab:10mg/ml | Cytotoxic (anti-neoplastic) drugs
Alternate brands of MABTHERA 10mg|ml Injection 50mlx1s
| Brand Name | Price | Savings |
|---|---|---|
| MABTHERA 10mg|ml Injection 10mlx2s | ₨ 46,000.00 | You can save 68000 |
Manufactured / Marketed By : Roche Product Form : InjectionPack Size : 50mlx1sIngredients : Rituximab:10mg/mlGeneric Category : Cytotoxic (anti-neoplastic) drugs
How it works
MABTHERA 10mg|ml Injection 50mlx1s prevents the growth and spread of cancer cells in the body.
Side effects
Major & minor side effects for MABTHERA 10mg|ml Injection 50mlx1s
- Low blood pressure
- Nausea and Vomiting
- Chills and fever
- Abdominal pain
- Decrease in white blood cells and platelets
- Itching
- Infections severe
- Headache
- Muscle aches and pain
- Cough
Uses of MABTHERA 10mg|ml Injection 50mlx1s
What is it prescribed for?
-
Non-Hodgkin's Lymphoma
This medicine is used in the treatment of non-Hodgkin's lymphoma, a type of cancer that affects certain cells (lymphocytes) of the lymphatic system.
-
Chronic Lymphocytic Leukaemia
This medicine is used in the treatment of chronic lymphocytic leukemia, a type of blood cancer.
-
Rheumatoid Arthritis
This medicine is used in the treatment of Rheumatoid Arthritis, a chronic condition that can affect many joints.
-
Granulomatosis with polyangiitis and microscopic polyangiitis
This medicine is used in a combination with other medicines for the treatment of granulomatosis with polyangiitis and microscopic polyangiitis, chronic conditions that affect the blood vessels and may cause damage to the organs.
Concerns
Frequently asked questions
-
Onset of action
The initial response to this medicine can be observed within 7 to 14 days of administration.
-
Duration of Effect
The effect of this medicine can be detected for up to 6 months after completion of the treatment.
-
Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
-
Is it habit forming?
No habit-forming tendencies were reported.
-
Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
-
Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding for a specific period of time or prescribe an alternative medicine based on your clinical condition.
When not to use?
-
Allergy
This medicine is not recommended for use in patients with a known allergy to MABTHERA 10mg|ml Injection 50mlx1s , any murine proteins, or any other inactive ingredients present along with it.
-
Active infections
This medicine is not recommended for use in patients suffering from active, severe infections due to the increased risk of worsening of the patient's condition.
-
Severe immunocompromise
This medicine is not recommended for use in patients with severe immunocompromise since it may worsen the patient's condition.
Warnings
-
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
-
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding for a specific period of time or prescribe an alternative medicine based on your clinical condition.
-
Infusion related reactions
This medicine has been associated with severe infusion-related reactions, characterized by symptoms such as fever, chills, rigors, low blood pressure, hives, swelling, etc. The onset of these reactions usually ranges from 30 minutes to 2 hours after starting the first intravenous infusion. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition of the patient.
-
Infections
This medicine should be used with caution due to the increased risk of severe and potentially life-threatening infections. Report any unusual symptoms such as a fever, diarrhea, sore throat, pain or burning during urination, etc. to the doctor immediately. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases.
Dosage
-
Missed Dose
This medicine is usually given in multiple cycles. If you miss a scheduled appointment for receiving a dose of this medicine, call your doctor immediately for further instructions.
-
Overdose
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Interactions
Interaction with Medicines- Live attenuated vaccines and related products severe
- Adalimumab severe
- Topotecan moderate
-
severe
This medicine should be used with extreme caution in patients suffering from autoimmune disorders due to the increased risk of progressive multifocal leukoencephalopathy (PML) and death. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
-
severe
This medicine should be used with extreme caution in patients suffering from diseases of the heart due to the increased risk of worsening of the patient's condition. Close monitoring of heart function and vital signs is recommended for such patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.
-
severe
This medicine should be used with extreme caution in patients with a history of Hepatitis B infection due to the increased risk of recurrent outbreaks and worsening of the patient's condition. Close monitoring of clinical condition, appropriate corrective measures, and replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
-
severe
This medicine should be used with extreme caution due to the increased risk of tumor lysis syndrome. This risk is especially higher in patients suffering from electrolyte abnormalities and kidney diseases. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition off the patient.
-
moderate
This medicine should be used with extreme caution in patients with a known history of bone marrow suppression since it may worsen the patient's condition. Close monitoring of complete blood cell counts is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
-
moderate
This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of serious adverse effects. Close monitoring of kidney function tests is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.
General Instructions
This medicine is usually administered by a qualified healthcare professional in the hospital or clinical setting. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines including any herbs and supplements as well as your medical conditions before receiving this medicine. Report any unusual and significant side effects to the doctor immediately.
Other details
- Usage does not depend on food timings
- To be taken as instructed by doctor
- May cause sleepiness
References
- practo.com - Rituximab [Internet]. Available from: https://www.practo.com/medicine-info/rituximab-1630-api [cited 2 october 2019]. 28 Aug 2018
One of the following licensed pharmacy from the nearest location will deliver MABTHERA 10mg|ml Injection 50mlx1s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Related products
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.